Results 311 to 320 of about 120,861 (346)

Deprescribing Proton Pump Inhibitors

JAMA Internal Medicine, 2020
Jacob E, Kurlander, Juan J, Gonzalez, Sameer D, Saini   +2 more
openaire   +4 more sources

Proton pump inhibitors

British Dental Journal, 2010
  +5 more sources

Proton pump inhibitors

Reactions Weekly, 2020
Felice Schnoll-Sussman, Rachel Niec, Philip O. Katz   +2 more
openaire   +2 more sources

▼Lansoprazole - another proton pump inhibitor

Drug and Therapeutics Bulletin, 1995
Lansoprazole (Zoton - Lederle) is a proton pump inhibitor recently licensed for the treatment of duodenal ulcer, benign gastric ulcer or reflux oesophagitis. It is structurally related to omeprazole, which has now been available in the UK for 6 years. In this article we consider the place of lansoprazole in the treatment of patients with acid-related ...
openaire   +2 more sources

Proton Pump Inhibitors

Clinical Gastroenterology and Hepatology, 2006
  +5 more sources

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Proton pump inhibitors

Medical Journal of Australia, 1998
openaire   +2 more sources

[Proton pump inhibitors].

Pharmazie in unserer Zeit, 2005
Manfred, Schubert-Zsilavecz, Holger, Stark   +1 more
openaire   +3 more sources

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp
exaly  

Proton pump inhibitors

Reactions Weekly, 2019
openaire   +2 more sources